Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neoplasms 1 Kidney Neoplasms 1 Glioblastoma 1 Coronary Artery Disease 1 Clear-cell metastatic renal cell carcinoma 1 Breast Neoplasms 1

Interventions

aldesleukin 43 Sunitinib 42 Cyclophosphamide 30 Nivolumab 29 pembrolizumab 27 Everolimus 27 Interferon-alpha 25 Bevacizumab 23 Sorafenib 22 Interleukin-2 20 fludarabine phosphate 19 Radiotherapy 18 Ipilimumab 18 Filgrastim 18 Axitinib 18 Gene Expression Profiling 16 Peripheral Blood Stem Cell Transplantation 15 Gemcitabine 15 cabozantinib 14 Radiosurgery 13 fludarabine 11 Doxorubicin 11 Carboplatin 11 Blood Specimen Collection 11 temsirolimus 10 atezolizumab 9 Immunohistochemistry 9 Etoposide 9 Chemotherapy, Adjuvant 9 sargramostim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × Molecular Imaging × Clear all

NCT02228954 2021-12-07

IMPACT-RCC

Radboud University Medical Center

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡